Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 1 |
2022 | 3 |
2023 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Role of 5-HT7 receptors in the immune system in health and disease.
Mol Med. 2019 Dec 31;26(1):2. doi: 10.1186/s10020-019-0126-x.
Mol Med. 2019.
PMID: 31892309
Free PMC article.
Review.
Central nervous system effects of 5-HT7 receptors: a potential target for neurodegenerative diseases.
Quintero-Villegas A, Valdés-Ferrer SI.
Quintero-Villegas A, et al.
Mol Med. 2022 Jun 20;28(1):70. doi: 10.1186/s10020-022-00497-2.
Mol Med. 2022.
PMID: 35725396
Free PMC article.
Review.
Item in Clipboard
Pyridostigmine reduces mortality of patients with severe SARS-CoV-2 infection: A phase 2/3 randomized controlled trial.
Fragoso-Saavedra S, Núñez I, Audelo-Cruz BM, Arias-Martínez S, Manzur-Sandoval D, Quintero-Villegas A, Benjamín García-González H, Carbajal-Morelos SL, PoncedeLeón-Rosales S, Gotés-Palazuelos J, Maza-Larrea JA, Rosales-de la Rosa JJ, Diaz-Rivera D, Luna-García E, Piten-Isidro E, Del Río-Estrada PM, Fragoso-Saavedra M, Caro-Vega Y, Batina I, Islas-Weinstein L, Iruegas-Nunez DA, Calva JJ, Belaunzarán-Zamudio PF, Sierra-Madero J, Crispín JC, Valdés-Ferrer SI.
Fragoso-Saavedra S, et al. Among authors: quintero villegas a.
Mol Med. 2022 Nov 8;28(1):131. doi: 10.1186/s10020-022-00553-x.
Mol Med. 2022.
PMID: 36348276
Free PMC article.
Clinical Trial.
Item in Clipboard
Epidemiological and clinical characteristics of patients with human monkeypox infection in Mexico: a nationwide observational study.
Núñez I, García-Grimshaw M, Ceballos-Liceaga SE, Toledo-Salinas C, Carbajal-Sandoval G, Sosa-Laso L, García-Rodríguez G, Cortés-Alcalá R, Torre A, Fragoso-Saavedra S, Quintero-Villegas A, López-Gatell H, Reyes-Terán G, Valdés-Ferrer SI.
Núñez I, et al. Among authors: quintero villegas a.
Lancet Reg Health Am. 2023 Jan;17:100392. doi: 10.1016/j.lana.2022.100392. Epub 2022 Nov 10.
Lancet Reg Health Am. 2023.
PMID: 36405887
Free PMC article.
Item in Clipboard
A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocol.
Fragoso-Saavedra S, Iruegas-Nunez DA, Quintero-Villegas A, García-González HB, Nuñez I, Carbajal-Morelos SL, Audelo-Cruz BM, Arias-Martínez S, Caro-Vega Y, Calva JJ, Luqueño-Martínez V, González-Duarte A, Crabtree-Ramírez B, Crispín JC, Sierra-Madero J, Belaunzarán-Zamudio PF, Valdés-Ferrer SI.
Fragoso-Saavedra S, et al. Among authors: quintero villegas a.
BMC Infect Dis. 2020 Oct 16;20(1):765. doi: 10.1186/s12879-020-05485-7.
BMC Infect Dis. 2020.
PMID: 33066761
Free PMC article.
Item in Clipboard
Cite
Cite